Article

Basil Polysaccharide Reverses Development of Experimental Model of Sepsis-Induced…

Mediators of Inflammation · 2021 · Xi Chen, author Yue He, author Qiang Wei, author Chuanjiang Wang, author Rômulo Dias Novaes, Academic Editor

Key facts

Title Basil Polysaccharide Reverses Development of Experimental Model of Sepsis-Induced Secondary Staphylococcus aureus Pneumonia
First author Xi Chen, author Yue He, author Qiang Wei, author Chuanjiang Wang, author Rômulo Dias Novaes, Academic Editor
Journal Mediators of Inflammation
Published Feb 20, 2021
DOI 10.1155/2021/5596339
Product codes mentioned MVU

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature